Later, we and other researchers assessed GCase activity in the blood and mononuclear cells of GBA-carriers and demonstrated that GCase activity is also reduced in healthy GBA mutation carriers without PD and could not discriminate PD status in GBA mutation carriers [16,36]. This evidence concerns the gene GBA1 and Parkinson disease.